Silverfin false false 31/03/2026 01/04/2025 31/03/2026 Mrs A M Aldridge 06/11/2013 Mrs J R Boyle 23/02/2015 Mr M J Chapman 02/01/2025 Mr H N Ginsberg 03/02/2025 30 June 2026 The principal activity of the company during the year was the provision of a research and education forum on the biology of the PCSK9 gene 08728508 2026-03-31 08728508 bus:Director1 2026-03-31 08728508 bus:Director2 2026-03-31 08728508 bus:Director3 2026-03-31 08728508 bus:Director4 2026-03-31 08728508 2025-03-31 08728508 core:CurrentFinancialInstruments 2026-03-31 08728508 core:CurrentFinancialInstruments 2025-03-31 08728508 core:RetainedEarningsAccumulatedLosses 2026-03-31 08728508 core:RetainedEarningsAccumulatedLosses 2025-03-31 08728508 core:OtherPropertyPlantEquipment 2025-03-31 08728508 core:OtherPropertyPlantEquipment 2026-03-31 08728508 2025-04-01 2026-03-31 08728508 bus:FilletedAccounts 2025-04-01 2026-03-31 08728508 bus:SmallEntities 2025-04-01 2026-03-31 08728508 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 08728508 bus:CompanyLimitedByGuarantee 2025-04-01 2026-03-31 08728508 bus:Director1 2025-04-01 2026-03-31 08728508 bus:Director2 2025-04-01 2026-03-31 08728508 bus:Director3 2025-04-01 2026-03-31 08728508 bus:Director4 2025-04-01 2026-03-31 08728508 core:OtherPropertyPlantEquipment core:BottomRangeValue 2025-04-01 2026-03-31 08728508 core:OtherPropertyPlantEquipment core:TopRangeValue 2025-04-01 2026-03-31 08728508 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 08728508 (England and Wales)

PCSK9 EDUCATION AND RESEARCH FORUM

(A COMPANY LIMITED BY GUARANTEE)

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH THE REGISTRAR

PCSK9 EDUCATION AND RESEARCH FORUM

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026

Contents

PCSK9 EDUCATION AND RESEARCH FORUM

BALANCE SHEET

AS AT 31 MARCH 2026
PCSK9 EDUCATION AND RESEARCH FORUM

BALANCE SHEET (continued)

AS AT 31 MARCH 2026
Note 2026 2025
£ £
Current assets
Stocks 0 2,000
Debtors 4 17,567 8,513
Cash at bank and in hand 97,249 113,410
114,816 123,923
Creditors: amounts falling due within one year 5 ( 122,800) ( 125,334)
Net current liabilities (7,984) (1,411)
Total assets less current liabilities (7,984) (1,411)
Net liabilities ( 7,984) ( 1,411)
Reserves
Profit and loss account ( 7,984 ) ( 1,411 )
Total reserves ( 7,984) ( 1,411)

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of PCSK9 Education and Research Forum (registered number: 08728508) were approved and authorised for issue by the Board of Directors on 30 June 2026. They were signed on its behalf by:

Mrs J R Boyle
Director
PCSK9 EDUCATION AND RESEARCH FORUM

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
PCSK9 EDUCATION AND RESEARCH FORUM

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

PCSK9 Education and Research Forum (the Company) is a private company, limited by guarantee, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Minerva Mill Innovation Centre, Station Road, Alcester, B49 5ET, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 3 - 0 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 5 5

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2025 146 146
At 31 March 2026 146 146
Accumulated depreciation
At 01 April 2025 146 146
At 31 March 2026 146 146
Net book value
At 31 March 2026 0 0
At 31 March 2025 0 0

4. Debtors

2026 2025
£ £
Trade debtors 17,442 8,358
Other debtors 125 155
17,567 8,513

5. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 11,158 498
Taxation and social security 0 178
Other creditors 111,642 124,658
122,800 125,334

6. Liability of members

The members of the PCSK9 Education and Research Forum have undertaken to contribute a sum not exceeding £1 each to meet the liabilities of the Company if it should be wound up.